Gennao Bio

Gennao Bio is a privately held company based in Hopewell, New Jersey. The company employs 24 people and generates over $10,000 in annual revenue. Gennao Bio specializes in developing genetic medicines, specifically targeted nucleic acid therapeutics. Their proprietary gene monoclonal antibody (GMAB) platform technology allows for the non-covalent binding and systemic delivery of various nucleic acid payloads, such as mRNA, synthetic RNA, DNA, si-RNA, ASOs, and gene-editing molecules, to target cells. This non-viral delivery system distinguishes itself from traditional gene delivery methods by enabling the delivery of multiple nucleic acid types, facilitating repeat dosing, and utilizing established manufacturing processes. Gennao Bio's GMAB platform is focused on addressing critical medical needs in oncology and rare monogenic skeletal muscle diseases. For more information, visit Gennao Bio's website at gennao.com.